about membership activities meetings resources feedback home

 

IART Meeting Minutes

Meeting Minutes

IART Steering Committee

Nashville, TN

3/16/2002

 

Attendees:ü

Il Je Yu, Korean Board of Toxicology
Claire Chamber, EUROTOX
John Fowler, EUROTOX
Ikuo Horii, JST
Mamoru Nomura, JST
James Bus, IUTOX
Tetsuo Satoh, IUTOX
Peter McAnulty, ABT
Bob Poppenga, ABVT
Maritza Rojas Martini, ALATOX, Guest
Hitoshi Endou, Observer 

The meeting was Co-Chaired by Dr. Tetsuo Satoh and Dr. Jim Bus 

 

AGENDA ITEM 1:ü Welcome and Opening of the Meeting 

The meeting was called to order at 1:10 PM. 

 

AGENDA ITEM 2:ü Organizational Matters

No other business was suggested.ü The Agenda as distributed was adopted.

 

AGENDA ITEM 3:ü Minutes of the Informal IART SC Meeting (9/15/2001)

Dr. Satoh brought the Committee up to date regarding the IART meeting in Istanbul, held in conjunction with EUROTOX, 2001.ü The Minutes from that meeting were reviewed and approved.

 

AGENDA ITEM 4:ü Formulation and Approval of By-Laws

Dr. Satoh thanked Dr. Art Craigmill on behalf of the Committee for his efforts to formulate IART By-Laws.üü The officers will thank Art personally for all of his efforts on behalf of the Committee.

Dr. Bus indicated that the MOU between IART and IUTOX and IARTOs draft By-Laws were accepted by IUTOX at its recent meeting in Brisbane.ü

Dr. Bus indicated that one of the first orders of business of the current meeting was to elect IART officers.ü Dr. John Fowler indicated that perhaps discussion of the draft By-Laws would be in order since there were several issues that would be worth discussion, specifically issues related to geographic distribution of Officers and some issues of continuity of leadership for the Committee.ü

Dr. Bus responded that any changes to the draft By-Laws would be unlikely to affect IUTOX approval.ü

Dr. Fowler began the discussion of the By-Laws:

 

  • What do the Articles of Incorporation pertain to?ü
    • Perhaps the By-Law Title should include Articles of Incorporation
  • We should be consistent in terminology Ç -Board" vs. -Committee" and -Directors" vs. -Officers".ü
    • Use -Executive Board"
    • Use -Officers"
  •  Should there be some indication in the By-Laws that geographic diversity is desirable?
    • Probably no need to spell out in the By-Laws but accept the concept that geographic diversity is certainly a goal of the Board and should be considered in the election of Officers.
    • ACTION:ü this should be a guideline and not incorporated into By-Laws.
  •  There are some issues of eligibility for office.ü
    • For example, would Dr. Satoh be eligible to run for office since he will not be an official representative of the JST?ü Also, according to the By-Law wording, it would not be possible to have a representative from Latin America.
    • ACTION:ü Dr. Satoh is willing to be JST nominee.
  •  We should restrict the discussion today to the -spirit" of the By-Laws and refine them at a later time.
    •  Section 2 should provide for some continuity of the Committee leadership.ü
    • Again, we should proceed with the Election of Officers and then work out the details of their term of office.
  •  Section 4 should provide for a longer time frame of 10 days.ü
    •  There was general agreement that 30 days would be more appropriate.
    •  The suggestion was made to change the wording to -Notice of meeting shall be given by the secretary by first class mailþ." to -Notice of meeting shall be given by the secretary by electronic mail and confirmed by regular mailþ.".
    • The Board will decide when and where to meet.
  •  The wording of Section 5 is not clear.
    •  No suggested changes were proposed.
  •  Section 6:ü no prior mention of Past-President.ü Perhaps this should be clarified.
    • As mentioned in the draft By-Laws, the immediate Past-President will sit on the Executive Board
  •  Article III:ü wording refinement will probably be necessary.ü For example, the duties of the Secretary Ç Treasurer should be spelled out in some detail.
  •  Dr. Bus mentioned that specifics regarding the nature of the IUTOX-IART Liaison are somewhat vague at this point.ü This will be important to further define.ü For example, it will be important to define how the educational efforts of IUTOX will be directed.ü Emphasis should be placed on developing regions of the world since developed regions are already prepared to provide appropriate education.
  •  ABT advised that they did not have a representative identified but that Dr. Craigmill could not continue to be the ABT representative.ü They will advise in due course and hoped that the representative would be invited to join the Board.
 

AGENDA ITEM 5:ü Election of the Executive Board

 
Election of Officers proceeded.ü Nominations were sought and -availability" of the individuals proposed was questioned to ensure future continuity should IART be successful.
 
Unanimous approval was given to the following with affiliations to MOU signatory in brackets:
 
Dr. Tetsuo Satoh (JST) was elected President
Dr. John Fowler (EUROTOX and ATS) was elected V-P
Dr. Bob Poppenga (ABVT) was elected Secretary Ç Treasurer
 
The desirability of additional members on the Executive Board was then discussed.ü This is an issue that can be addressed at a later time under Article II, Section 8.ü
 
Terms of office were discussed.ü Suggested terms were 1 year for Dr. Satoh; a minimum of a two-year commitment by Dr. Fowler.ü It was suggested that the Secretary Ç Treasurer term should be 3 years.
 
ACTION:ü (subsequently Ç on basis that the minimum periods nominated above did not allow sufficient continuity) Dr. Satoh was elected President (for 2 years, then 2 further years as Past President); Dr. Fowler intended to commit to IART for 4 years (VP for 2 years) if possible/subject to proper election; Dr. Bob Poppenga intended to commit to IART for 6 years (Secretary/Treasurer for 3 years) if possible/subject to proper election.
Envisaged that an ABT person would in time be co-opted.
 

AGENDA ITEM 6:ü Financial Issues for Future Activities

 
Discussion turned to financing the Committee.ü How should this be approached?ü
 
Up to this point, Committee meetings have been -sponsored" by participating organizations.ü Perhaps this can continue.ü However, this sponsorship may be less appropriate or appealing if only the Executive Board is meeting.
 

Participating organizations could be -assessed" a membership fee.

Dr. Horii mentioned that the JST is willing to donate $2000 US for future IART activities.
 
Would there be resources to support the travel of representatives from underdeveloped regions?
üIUTOX has agreed to support one observer to IART meetings 

In general, industry support would be difficult to obtain at the present time until the IART mission is better defined and there is a track record of achievement.

Educational efforts may garner industry support.
 
Dr. Yu suggested that we should establish an IART website to promote our mission and activities.ü
 
IUTOX has agreed to sponsor an IART website.
 
Conversation turned toward what would be appropriate IART website content.
 
  • Example questions
  • Course materials
  • Membership Lists
  • How IART participating groups approach certification
  • Links to other appropriate sites

 

Dr. Rojas mentioned that the website should serve to motivate organization in developing regions.

It was mentioned that Dr. Craigmill would be an ideal webmaster.üü Dr. Craigmill should be contacted about website possibilities.

Cost of the website was discussed in general terms.ü This should be explored further.

Perhaps an upfront -loan" could be provided from a participating organization as -seed" money.

We need to decide what our niche will be.ü What will be IARTOs unique contribution to toxicology?

  • One unique niche would be to provide an international registry of recognized toxicologic specialists.

Individuals should be invited to allow their names to be listed on the site, since this was the proper thing to do and it would negate the need to ask IART signatory organizations to release their membership lists. 

Individuals would not be charged for being listed.

Individuals wishing to access the lists would be charged.ü It was suggested that a credit card charge of ~ $20 US would be appropriate.

ACTION:ü approach webmaster to establish a more detailed plan.

 

  •  Another unique niche might be to recognize or certify continuing education programs.

 

AGENDA ITEM 7:ü International Certification/Titles for Toxicologists of the IART Member Organizations

 

The member organizations of the IART have their own title for certified toxicologists (DABT, DABVT, Fellow, ATS, DJST, EUROTOX Registry, DKBT).

Dr. Satoh proposed two possibilities for certified toxicologists worldwide.ü For example, Internationally Recognized Toxicologist (IRT) or IART Certified Toxicologist were suggested.ü This would not exclude existing titles, but serve to establish a globally recognized title.ü All toxicologists who are certified by the IART member organizations can use one of their own title such as DABT or IRT or both.ü There was no strong objection on this proposal and it was approved in principle.ü Tentatively, the proposed title would be Internationally Recognized Toxicologist (IRT).

 

AGENDA ITEM 8:ü The Latin American Situation (ALATOX)

The general discussion was brought to a close.üü Dr. Maritza Rojas gave a presentation entitled -Certification of Toxicologists:ü The Latin American Case"

  • There is considerable variation among LA countries in terms of what a qualified toxicologist actually is.
  • Governments do not recognize the importance of qualified toxicologists.ü Thus, existing toxicologists lack influence within the respective governmental agencies.
  • One idea would be for IART to support respective national societies so that they might in turn become a resource to governments in setting and implementing standards.

 

For IUTOX, it is difficult to even identify individuals in developing countries to provide leadership in the area of toxicology.

One of the major missions of IART is to elevate the practice of toxicology throughout the developing world.

Dr. Il Je Yu provided Committee members with a progress report from the Korean Board of Toxicology.ü

Dr. Bus was thanked for his excellent input throughout the formative stages of the IART process.

 The meeting was adjourned by Dr. Satoh at ~ 4 PM.

 

Respectively submitted,

 Dr. Robert Poppenga, Secretary Ç Treasurer

 

 

 

Contact IUTOX at: iutoxhq@iutox.org For web technical issues contact: webtech@iutox.org
Copyright © 2008 by IUTOX.